Skip to main content
. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675

Figure 2.

Figure 2

Clinical photos of core dermatologic immune-related adverse events (D-irAE) diagnoses. (A) ICI-Psoriasis; (B) ICI-Lichen planus; (C) ICI-Bullous pemphigoid; (D) ICI-Vitiligo; (E) ICI-Grovers; (F) ICI-Eczematous dermatitis; (G) ICI-Exanthem; (H) ICI-Eruptive atypical squamous proliferation, (I) ICI-Erosive mucocutaneous. ICI, Immune checkpoint inhibitor.